Novonix (NVNXF) Total Current Liabilities (2020 - 2025)

Novonix has reported Total Current Liabilities for 6 years, with the latest figure at $83.6 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 80.7% year-over-year to $83.6 million; the trailing twelve-month figure through Dec 2025 stood at $83.6 million (up 80.7% YoY), and the FY2025 full-year result was $83.6 million, up 80.7% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $83.6 million, up from $76.5 million in the prior quarter.
• The five-year high for Total Current Liabilities was $83.6 million in Q4 2025, with the low at $3.8 million in Q4 2021.
• Historically, Total Current Liabilities has averaged $28.4 million across 5 years, with a median of $8.9 million in 2022.
• Annual changes were most pronounced in 2023 — Total Current Liabilities retreated 24.13% — and 2025, when it jumped 713.28%.
• Novonix's Total Current Liabilities stood at $3.8 million in 2021, then surged by 120.0% to $8.5 million in 2022, then soared by 340.17% to $37.3 million in 2023, then grew by 24.1% to $46.2 million in 2024, then surged by 80.7% to $83.6 million in 2025.
• The last three Total Current Liabilities figures came in at $83.6 million (Q4 2025), $76.5 million (Q2 2025), and $46.2 million (Q4 2024), per Business Quant data.